Two very different groups of companies will emerge from the lockdown: thousands with liquidity problems and uncertain futures, and hundreds with piles of cash and an appetite for growth. That means there’s a coming surge in mergers and acquisitions.… Continue Reading
Most of us, if we have any sense at all, harbor some healthy distrust of the world’s biggest companies. For good reason we fear the concentrated power of giant corporations. What, after all, is one person compared to the overwhelming might of Facebook, Walmart, or Exxon?… Continue Reading
Employer: Pfizer Inc.
Location: New York, New York USA
Description: Pfizer’s Anti-Corruption Program Office has global responsibility for Pfizer’s anti-corruption policy/procedure along with implementation, application, training, and similar related activities in support of the program. … Continue Reading
The Department of Justice Fraud Section said this month it has hired Hui Chen as a “full-time compliance expert.”
She comes to the DOJ with practical experience in anti-corruption and corporate compliance at Standard Chartered Bank, Pfizer, and Microsoft, along with prior enforcement experience as a federal prosecutor.… Continue Reading
In a speech Tuesday at CBI’s Annual Pharmaceutical Compliance Congress in Washington D.C., the head of the SEC’s enforcement division, Andrew Ceresney, left, talked about the most common ways pharmas violate the FCPA.… Continue Reading
Job Title: Senior Corporate Counsel, Transactions Compliance Lead
Location: New York, NY
Support from a compliance perspective the execution of complex business development transactions such as mergers and acquisitions, joint ventures, and licensing transactions among others. … Continue Reading
A survey by Saudi Arabia’s National Anti-Corruption Commission found that 67.8 percent of the respondents believe financial and state corruption is on the rise in the country.
Hewlett-Packard’s $108 million settlement this week didn’t quite make our list of the top ten FCPA cases of all time. But with a disgorgement to the SEC of $26.4 million, H-P landed eleventh on the list of the biggest FCPA disgorgements.… Continue Reading
Big-pharma Merck said an SEC filing Thursday that the DOJ has closed its FCPA investigation of the company.
Merck first disclosed in 2010 that it received letters from the DOJ and SEC asking for FCPA-related information about its activities in a number of countries.… Continue Reading